Document Detail

Prevention of severe acute pancreatitis with octreotide in obese patients: a prospective multi-center randomized controlled trial.
MedLine Citation:
PMID:  23086244     Owner:  NLM     Status:  In-Data-Review    
OBJECTIVES: To evaluate the efficacy of octreotide in preventing severe acute pancreatitis (SAP) in obese patients.
METHODS: A prospective multi-center partly randomized control trial was conducted in patients with mild acute pancreatitis (AP). Nonobese patients received conventional management (nonobese-C, n = 82), whereas obese patients (body mass index ≥25 kg/m) were randomized into 2 groups: obese-C (n = 79), who received conventional management, and obese-C+O (n = 82), who received conventional management plus intravenous infusion of octreotide, 50 μg/h for 72 hours.
RESULTS: The risk ratio and relative risk reduction in the development of SAP in the obese-C+O group were 0.27 (95% confidence interval, 0.10-0.69) and 0.73 (95% confidence interval, 0.31-0.90), respectively. The number of cases developing local complications in the obese-C+O group was significantly smaller than that in the obese-C group: 4.9% vs 19%, P = 0.006. The plasma level of somatostatin in the obese-C+O group was significantly higher than that in the obese-C group: 165.5 ± 42.6 vs 112.1 ± 24.86 pg/mL, P < 0.05. Supplement of octreotide also accompanied with reduction in plasma levels of tumor necrosis factor α and IL-6.
CONCLUSIONS: Intravenous administration of octreotide (50 μg/h) for 72 hours in the early stage of AP could prevent the development of SAP effectively in obese patients by raising plasma somatostatin to a normal level and reducing circulating cytokines.
Fan Yang; Hao Wu; Yanqing Li; Zhaoshen Li; Chunhui Wang; Jinlin Yang; Bing Hu; Zhiyin Huang; Rui Ji; Xianbao Zhan; Huizhong Xie; Lei Wang; Mingguang Zhang; Chengwei Tang
Related Documents :
15746454 - Safety and efficacy of endovascular treatment of carotid artery stenosis compared with ...
8303744 - Predicting the disability of first-time stroke sufferers at 1 year. 12-month follow-up ...
3630644 - Motor loss and swallowing difficulty after stroke: frequency, recovery, and prognosis.
20303694 - Open surgery remains a valid option for the treatment of recurrent carotid stenosis.
22854394 - Perineural clonidine does not prolong levobupivacaine 0.5% after sciatic nerve block us...
22395054 - A comparison of levobupivacaine and levobupivacaine-tramadol combination in bilateral i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Pancreas     Volume:  41     ISSN:  1536-4828     ISO Abbreviation:  Pancreas     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-10-22     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8608542     Medline TA:  Pancreas     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1206-12     Citation Subset:  IM    
From the *Departments of Gastroenterology, West China Hospital, Sichuan University; †Qilu Hospital, Shandong University; ‡Changhai Hospital, The Second Military Medical University; and §The First Hospital Affiliated to Xinjiang Medical University, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interventions for Necrotizing Pancreatitis: Summary of a Multidisciplinary Consensus Conference.
Next Document:  Smoking and the course of recurrent acute and chronic alcoholic pancreatitis: a dose-dependent relat...